Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Paratek Pharmaceuticals Inc"
Count: 15
Selected: 0
NCT IDTitle
NCT04922554Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)
NCT05217537Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections
NCT04779242Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia
NCT04160260Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia
NCT00865280Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
NCT03716024Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
NCT03757234IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis
NCT03425396Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis
NCT02378480Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)
NCT02531438Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)
NCT02877927Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI
NCT00876850Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
NCT04460586Pharmacokinetics of Omadacycline in Cystic Fibrosis
NCT04144374Omadacycline Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis
NCT05515562Effects of Intravenous (IV) Omadacycline on Gut Microbiome